189 related articles for article (PubMed ID: 24391204)
1. Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.
Sjölund-Karlsson M; Howie RL; Crump JA; Whichard JM
J Clin Microbiol; 2014 Mar; 52(3):877-84. PubMed ID: 24391204
[TBL] [Abstract][Full Text] [Related]
2. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G
J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quinolones for use in detection of determinants of acquired quinolone resistance, including the new transmissible resistance mechanisms qnrA, qnrB, qnrS, and aac(6')Ib-cr, in Escherichia coli and Salmonella enterica and determinations of wild-type distributions.
Cavaco LM; Aarestrup FM
J Clin Microbiol; 2009 Sep; 47(9):2751-8. PubMed ID: 19571019
[TBL] [Abstract][Full Text] [Related]
4. Pefloxacin as a surrogate marker for quinolone susceptibility in
Sharma P; Dahiya S; Kumari B; Balaji V; Sood S; Das BK; Kapil A
Indian J Med Res; 2017 May; 145(5):687-692. PubMed ID: 28948961
[TBL] [Abstract][Full Text] [Related]
5. Revisit of fluoroquinolone and azithromycin susceptibility breakpoints for Salmonella enterica serovar Typhi.
Das S; Ray U; Dutta S
J Med Microbiol; 2016 Jul; 65(7):632-640. PubMed ID: 27221661
[TBL] [Abstract][Full Text] [Related]
6. Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
Parry CM; Thuy CT; Dongol S; Karkey A; Vinh H; Chinh NT; Duy PT; Thieu Nga TV; Campbell JI; Van Minh Hoang N; Arjyal A; Bhutta ZA; Bhattacharya SK; Agtini MD; Dong B; Canh DG; Naheed A; Wain J; Tinh Hien T; Basnyat B; Ochiai L; Clemens J; Farrar JJ; Dolecek C; Baker S
Antimicrob Agents Chemother; 2010 Dec; 54(12):5201-8. PubMed ID: 20837759
[TBL] [Abstract][Full Text] [Related]
7. Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation.
Acharya D; Malla S; Bhatta DR; Adhikari N; Dumre SP
Kathmandu Univ Med J (KUMJ); 2012; 10(37):24-9. PubMed ID: 22971857
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica.
Deak E; Skov R; Hindler JA; Humphries RM
J Clin Microbiol; 2015 Nov; 53(11):3405-10. PubMed ID: 26292293
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Ciprofloxacin and Levofloxacin Disk Diffusion and Etest Using the 2019
Humphries RM; Hindler JA; Shaffer K; Campeau SA
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567744
[TBL] [Abstract][Full Text] [Related]
10. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
[TBL] [Abstract][Full Text] [Related]
11. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
[No Abstract] [Full Text] [Related]
12. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
Casas MR; Camargo CH; Soares FB; da Silveira WD; Fernandes SA
Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
[TBL] [Abstract][Full Text] [Related]
13. Performance of Etest and disk diffusion for detection of ciprofloxacin and levofloxacin resistance in Salmonella enterica.
Deak E; Hindler JA; Skov R; Sjölund-Karlsson M; Sokovic A; Humphries RM
J Clin Microbiol; 2015 Jan; 53(1):298-301. PubMed ID: 25355768
[TBL] [Abstract][Full Text] [Related]
14. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
15. Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates.
Sutton LD; Jones RN
J Clin Microbiol; 1995 Jan; 33(1):146-8. PubMed ID: 7699031
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of Fluoroquinolone Resistance in Wisconsin: Geographic Variation and Impact of Revised CLSI Breakpoints.
Lazzerini G; Lavey SC; Fox BC; Munson E
Clin Med Res; 2022 Jun; 20(2):81-88. PubMed ID: 35086853
[No Abstract] [Full Text] [Related]
17. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
18. Renaissance of Conventional First-Line Antibiotics in
Khanal PR; Satyal D; Bhetwal A; Maharjan A; Shakya S; Tandukar S; Parajuli NP
Biomed Res Int; 2017; 2017():2868143. PubMed ID: 29018810
[TBL] [Abstract][Full Text] [Related]
19. Ofloxacin minimum inhibitory concentration versus disk diffusion zone diameter for Salmonella enterica serovar Typhi isolates: problems in the detection of ofloxacin resistance.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2003; 56(5-6):210-2. PubMed ID: 14695432
[TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test.
Ramakrishnan R; Ramesh S; Bharathi MJ; Amuthan M; Viswanathan S
Indian J Pathol Microbiol; 2010; 53(2):276-80. PubMed ID: 20551532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
